The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Inhibition of autoimmune encephalomyelitis by a tetracycline
Abstract
We have explored the use of minocycline, a tetracycline with antiinflammatory properties, to treat chronic relapsing-remitting experimental allergic encephalomyelitis, an animal model of multiple sclerosis. Therapeutic treatment with minocycline dramatically suppresses ongoing disease activity and limits disease progression. Disease suppression is associated with immune deviation in the periphery and with suppression of the inflammatory cascade in the central nervous system. This association is demonstrated by inhibition of microglial activation and metalloproteinase-2 expression, which results in a concomitant decrease in inflammation and demyelination. As an established antiinflammatory drug with neuroprotective properties, minocycline may provide a novel therapeutic agent for relapsing-remitting multiple sclerosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, MS patients that were treated with the antibiotic minocycline, a broad-spectrum tetracycline, have reduced rate of relapses and amelioration of several immunological parameters (such as IL-12p40, metalloproteinase-9, and soluble vascular cell adhesion molecule-1) (145, 146).”
From The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology (2020) · cites this paper as [146]
Citations
Cites
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases
Liblau, R., Singer, S. M., & McDevitt, H. O. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80068-9 · Cited by 1,111
Chen, M., Ona, V. O., Li, M., Ferrante, R. J., Fink, K., Zhu, S., Bian, J., Guo, L., Farrell, L. A., Hersch, S. M., et al. (2000) · Nature Medicine · doi:10.1038/77528 · Cited by 1,060
Yrjänheikki, J., Kauppinen, T. M., Keinänen, R., Goldsteins, G., Chan, P. H., & Koıstınaho, J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13496 · Cited by 1,040
Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia
Yrjänheikki, J., Keinänen, R., Pellikka, M., Hökfelt, T., & Koistinaho, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15769 · Cited by 1,006
MICROGLIA AS MEDIATORS OF INFLAMMATORY AND DEGENERATIVE DISEASES
González-Scarano, F., & Baltuch, G. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.219 · Cited by 984
Tikka, T., Fiebich, B. L., Goldsteins, G., Keinänen, R., & Koistinaho, J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02580.2001 · Cited by 958
Multiple Sclerosis and Chronic Autoimmune Encephalomyelitis
Kornek, B., Storch, M. K., Weissert, R., Wallstroem, E., Stefferl, A., Olsson, T. P., Linington, C., Schmidbauer, M., & Lassmann, H. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64537-3 · Cited by 935
Self-citationGlutamate excitotoxicity in a model of multiple sclerosis
Pitt, D., Werner, P., & Raine, C. S. (2000) · Nature Medicine · doi:10.1038/71555 · Cited by 744
Matrix metalloproteinases and diseases of the CNS
Yong, V. W., Forsyth, P. A., Bell, R. B., Krekoski, C. A., & Edwards, D. R. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01169-7 · Cited by 635
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 295
Hossain, M. Z., Unno, S., Ando, H., Masuda, Y., & Kitagawa, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102051 · Cited by 71
Amyloid β peptide-induced corpus callosum damage and glial activation in vivo
Jantaratnotai, N., Ryu, J. K., Kim, S. U., & McLarnon, J. G. (2003) · Neuroreport · doi:10.1097/00001756-200308060-00005 · Cited by 86
Effective combination of minocycline and interferon-β in a model of multiple sclerosis
Giuliani, F., Fu, S. A., Metz, L. M., & Yong, V. W. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.04.020 · Cited by 71
Boz, C., Özmenoğlu, M., Velioğlu, S., Kılınç, K., Örem, A., Alioğlu, Z., & Altunayoğlu, V. (2005) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2005.01.005 · Cited by 71
Si, Q., Cosenza, M., Kim, M.-O., Zhao, M., Brownlee, M., Goldstein, H., & Lee, S. C. (2004) · Journal of NeuroVirology · doi:10.1080/13550280490499533 · Cited by 71
Angiogenesis in multiple sclerosis: is it good, bad or an epiphenomenon?
Kirk, S., Frank, J. A., & Karlik, S. J. (2003) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2003.10.016 · Cited by 71
Peña‐Altamira, E., Prati, F., Massenzio, F., Virgili, M., Contestabile, A., Bolognesi, M. L., & Monti, B. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1121237 · Cited by 70
Toward the development of rational therapies in multiple sclerosis: what is on the horizon?
Hemmer, B., & Hartung, H. (2007) · Annals of Neurology · doi:10.1002/ana.21289 · Cited by 70
Disease-Modifying Agents for Multiple Sclerosis
Menge, T., Weber, M. S., Hemmer, B., Kieseier, B. C., von Büdingen, H. ‐., Warnke, C., Zamvil, S. S., Boster, A. L., Khan, O., Hartung, H. P., et al. (2008) · Drugs · doi:10.2165/0003495-200868170-00004 · Cited by 66
Brendecke, S. M., & Prinz, M. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0520-6 · Cited by 68
Promoting repair in multiple sclerosis: problems and prospects
Lubetzki, C., Williams, A., & Stankoff, B. (2005) · Current Opinion in Neurology · doi:10.1097/01.wco.0000169739.83793.e0 · Cited by 63
Targeting MMPs in Acute and Chronic Neurological Conditions
Yong, V. W., Agrawal, S. M., & Stirling, D. P. (2007) · Neurotherapeutics · doi:10.1016/j.nurt.2007.07.005 · Cited by 64
Takeuchi, H., Wang, J., Kawanokuchi, J., Mitsuma, N., Mizuno, T., & Suzumura, A. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.09.014 · Cited by 64
Planche, V., Panatier, A., Hiba, B., Ducourneau, E., Raffard, G., Dubourdieu, N., Maître, M., Lesté-Lasserre, T., Brochet, B., Dousset, V., et al. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.11.010 · Cited by 64
Influence of the Gut Microbiome on Autoimmunity in the Central Nervous System
Colpitts, S. L., & Kasper, L. H. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601438 · Cited by 61
Zhang, S., Goetz, B. D., & Duncan, I. D. (2002) · Glia · doi:10.1002/glia.10172 · Cited by 60
Self-citationFernández-Gómez, F.-J., Galindo, M. F., Gómez-Lázaro, M., González-García, C., Ceña, V., Aguirre, N., & Jordán, J. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.03.019 · Cited by 59
Quintero, E. M., Willis, L., Singleton, R., Harris, N., Huang, P., Bhat, N., & Granholm, A.-C. (2006) · Brain Research · doi:10.1016/j.brainres.2006.03.104 · Cited by 58
Combined treatment with atorvastatin and minocycline suppresses severity of EAE
Luccarini, I., Ballerini, C., Biagioli, T., Biamonte, F., Bellucci, A., Rosi, M. C., Grossi, C., Massacesi, L., & Casamenti, F. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.01.022 · Cited by 58
Beneficial Effects of Minocycline on Cuprizone Induced Cortical Demyelination
Skripuletz, T., Miller, E., Moharregh-Khiabani, D., Blank, A., Pul, R., Gudi, V., Trebst, C., & Stangel, M. (2010) · Neurochemical Research · doi:10.1007/s11064-010-0202-7 · Cited by 61
Shankaran, M., Marino, M. E., Busch, R., Keim, C., King, C. L., Lee, J. Y. H., Killion, S., Awada, M., & Hellerstein, M. K. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21389 · Cited by 58
Role of oral Minocycline in acute encephalitis syndrome in India – a randomized controlled trial
Kumar, R. K., Basu, A., Sinha, S., Das, M. K., Tripathi, P., Jain, A., Kumar, C., Atam, V., Khan, S., & Singh, A. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-016-1385-6 · Cited by 58
Ratai, E., Bombardier, J. P., Joo, C., Annamalai, L., Burdo, T. H., Campbell, J. H., Fell, R., Hakimelahi, R., He, J., Autissier, P., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010523 · Cited by 56
Almolda, B., González, B., & Castellano, B. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.03.021 · Cited by 53
Li, J., Ghiani, C. A., Kim, J. Y., Liu, A., Sandoval, J., deVellis, J., & Casaccia‐Bonnefil, P. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0184-08.2008 · Cited by 53
Environmental control of autoimmune inflammation in the central nervous system
Rothhammer, V., & Quintana, F. J. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2016.09.002 · Cited by 52
Ito, N., Obata, H., & Saito, S. (2009) · Anesthesiology · doi:10.1097/aln.0b013e3181b05f42 · Cited by 51
Minocycline Impedes African Trypanosome Invasion of the Brain in a Murine Model
Masocha, W., Rottenberg, M. E., & Kristensson, K. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.5.1798-1804.2006 · Cited by 51
PEG Minocycline-Liposomes Ameliorate CNS Autoimmune Disease
Hu, W., Metselaar, J. M., Ben, L.-H., Cravens, P. D., Singh, M. P., Frohman, E. M., Eagar, T. N., Racke, M. K., Kieseier, B. C., & Stüve, O. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004151 · Cited by 50
Eitas, T. K., Chou, W.-C., Wen, H., Gris, D., Robbins, G. R., Brickey, W. J., Oyama, Y., & Ting, J. P. ‐. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.533034 · Cited by 51
Hassanzadeh, K., Habibiasl, B., Farajnia, S., & Roshangar, L. (2010) · Neurotoxicity Research · doi:10.1007/s12640-010-9212-0 · Cited by 48
Tolerogenic dendritic cells are efficiently generated using minocycline and dexamethasone
Lee, J., Park, C., Jang, S., Kim, J.-W., Kim, S., Song, S., Kim, K., & Lee, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-15569-1 · Cited by 48
Effect of minocycline in experimental autoimmune encephalomyelitis
Nessler, S., Dodel, R. C., Bittner, A., Reuss, S., Du, Y., Hemmer, B., & Sommer, N. (2002) · Annals of Neurology · doi:10.1002/ana.10353 · Cited by 48
Machado, A., Herrera, A. J., Venero, J. L., Santiago, M., de Pablos, R. M., Villarán, R. F., Espinosa‐Oliva, A. M., Argüelles, S., Sarmiento, M., Delgado‐Cortés, M. J., et al. (2011) · ISRN Neurology · doi:10.5402/2011/476158 · Cited by 47
Neuroinflammation and brain–peripheral interaction in ischemic stroke: A narrative review
Cheng, W., Zhao, Q. C., Li, C., & Xu, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1080737 · Cited by 47
Matsumoto, Y., Park, I.-K., & Kohyama, K. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900871 · Cited by 46
Neuroprotective role of minocycline in co-cultures of human fetal neurons and microglia.
Filipovic, R., & Zečević, N. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2007.12.024 · Cited by 45
Irani, D. N., & Prow, N. A. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000263867.46070.e2 · Cited by 43
Protective effects of minocycline on experimental spinal cord injury in rats
Aras, M., Altaş, M., Motor, S., Dokuyucu, R., Yılmaz, A., Özgiray, E., Seraslan, Y., & Yılmaz, N. (2015) · Injury · doi:10.1016/j.injury.2015.05.018 · Cited by 42
Hou, Y., Ryu, C. H., Park, K., Kim, S. M., Jeong, C., & Jeun, S. (2013) · Stem cell research & therapeutics · doi:10.1186/scrt228 · Cited by 44
Minocycline added to subcutaneous interferon β‐1a in multiple sclerosis: randomized RECYCLINE study
Sørensen, P. S., Sellebjerg, F. T., Lycke, J., Färkkilä, M. A., Créange, A., Lund, C., Schluep, M., Frederiksen, J. L., Stenager, E., Pfleger, C., et al. (2016) · European Journal of Neurology · doi:10.1111/ene.12953 · Cited by 42
Defaux, A., Zurich, M.-G., Honegger, P., & Monnet-Tschudi, F. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.04.053 · Cited by 40
Remote control — triggering of brain autoimmune disease in the gut
Wekerle, H., Berer, K., & Krishnamoorthy, G. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.09.009 · Cited by 39
Jackson, S. J., Lee, J., Nikodemova, M., Fabry, Z., & Duncan, I. D. (2009) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e3181a41d23 · Cited by 38
Self-citationExperimental models of neuroprotection relevant to multiple sclerosis
Yong, V. W., Giuliani, F., Xue, M., Bar‐Or, A., & Metz, L. M. (2007) · Neurology · doi:10.1212/01.wnl.0000275230.20635.72 · Cited by 38
Hahn, J. N., Kaushik, D. K., Mishra, M. K., Wang, J., Silva, C. G., & Yong, V. W. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600436 · Cited by 37
Nikodémová, M., Lee, J., Fábry, Z., & Duncan, I. D. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.11.009 · Cited by 36
Self-citationKernt, M. (2010) · Clinical ophthalmology · doi:10.2147/opth.s11216 · Cited by 34
RetractedEffect of resveratrol and tetracycline on the subacute paraquat toxicity in mice
Satpute, R. M., Pawar, P., Puttewar, S., Sawale, S., & Ambhore, P. (2017) · Human & Experimental Toxicology · doi:10.1177/0960327116688070 · Cited by 34
Immunomodulatory role of the extracellular matrix protein tenascin-C in neuroinflammation
Wiemann, S., Reinhard, J., & Faissner, A. (2019) · Biochemical Society Transactions · doi:10.1042/bst20190081 · Cited by 34
Immunotherapy of Autoimmune Diseases with Nonantibiotic Properties of Tetracyclines
Park, C., Kim, S., & Lee, C. (2020) · Immune Network · doi:10.4110/in.2020.20.e47 · Cited by 34
Prospects for neuroprotection in multiple sclerosis
Yong, V. W. (2004) · Frontiers in bioscience · doi:10.2741/1276 · Cited by 33
Wiendl, H., & Kieseier, B. C. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.4.689 · Cited by 33
Stanisavljević, S., Dinić, M., Jevtić, B., Nikolovski, N., Momčilović, M. B., Đokić, J., Golić, N., Stojković, M. M., & Miljković, D. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00942 · Cited by 30
Strickland, B. A., Bakhsheshian, J., Emmanuel, B., Amar, A. P., Giannotta, S. L., Russin, J. J., & Mack, W. J. (2021) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2021.01.005 · Cited by 31
Kremlev, S. G., Roberts, R. L., & Palmer, C. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21380 · Cited by 33
Becker, E., Bengs, S., Aluri, S., Opitz, L., Atrott, K., Stanzel, C., Ruiz, P. A., Rogler, G., & Frey-Wagner, I. M. (2016) · Scientific Reports · doi:10.1038/srep37082 · Cited by 31
Kalish, R. S., & Koujak, S. (2004) · Clinical Immunology · doi:10.1016/j.clim.2004.07.012 · Cited by 32
Santi, L. D., Polimeni, G., Cuzzocrea, S., Esposito, E., Sessa, E., Annunziata, P., & Bramanti, P. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711795496881 · Cited by 32
Bai, X., Wang, X.-F., Zhang, L., Du, P., Cao, Z., & Hou, Y. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.07.143 · Cited by 31
Bender, A. M., Zapolanski, T., Watkins, S. A., Khosraviani, A., Seiffert-Sinha, K., Ding, W., Wagner, J. A., & Granstein, R. D. (2008) · Experimental Dermatology · doi:10.1111/j.1600-0625.2008.00716.x · Cited by 30
Converse, A. K., Larsen, E. C., Engle, J. W., Barnhart, T. E., Nickles, R. J., & Duncan, I. D. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.082743 · Cited by 29
Self-citationMinocycline Protects against Neurologic Complications of Rapid Correction of Hyponatremia
Kengne, F. G., Soupart, A., Pochet, R., Brion, J., & Decaux, G. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010050467 · Cited by 29
[Role of matrix metalloproteinases in the pathogenesis of multiple sclerosis].
Kurzepa, J., Bartosik-Psujek, H., Suchozebrska-Jesionek, D., Rejdak, K., Stryjecka‐Zimmer, M., & Stelmasiak, Z. (2005) · PubMed · Cited by 29
Oral Disease-Modifying Treatments for Multiple Sclerosis
Kieseier, B. C., & Wiendl, H. (2007) · CNS Drugs · doi:10.2165/00023210-200721060-00005 · Cited by 29
Lack of evidence of direct mitochondrial involvement in the neuroprotective effect of minocycline
Cornet, S., Spinnewyn, B., Delaflotte, S., Charnet, C., Roubert, V., Favre, C., Hider, H., Chabrier, P. E., & Auguet, M. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.10.039 · Cited by 28
Is Minocycline an Antiviral Agent? A Review of Current Literature
Nagarakanti, S., & Bishburg, E. (2015) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12444 · Cited by 27
Strahan, J. A., Walker, W. H., Montgomery, T. R., & Forger, N. G. (2016) · Developmental Neurobiology · doi:10.1002/dneu.22457 · Cited by 26
Alterations in CD200-CD200R1 System during EAE Already Manifest at Presymptomatic Stages
Valente, T., Serratosa, J., Perpiñá, U., Saura, J., & Solà, C. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00129 · Cited by 27
Antineuroinflammation of Minocycline in Stroke
Chen, Y., Cai, Z., & Ke, Z. (2017) · The Neurologist · doi:10.1097/nrl.0000000000000136 · Cited by 27
Combination Therapy for Multiple Sclerosis
Weinstock‐Guttman, B., & Bakshi, R. (2004) · CNS Drugs · doi:10.2165/00023210-200418120-00003 · Cited by 27
Niimi, N., Kohyama, K., & Matsumoto, Y. (2013) · Neuropathology · doi:10.1111/neup.12039 · Cited by 26
Doxycycline Attenuates Peripheral Inflammation in Rat Experimental Autoimmune Neuritis
Yi, C., Zhang, Z., Wang, W., Zug, C., Schluesener, H. J., & Zhang, Z. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0522-2 · Cited by 23
Ziemssen, T. (2005) · Journal of Neurology · doi:10.1007/s00415-005-5007-2 · Cited by 23
Boguszewska‐Czubara, A., Budzyńska, B., Skalicka‐Woźniak, K., & Kurzepa, J. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180514111500 · Cited by 22
Ruggieri, M., Pica, C., Lia, A., Zimatore, G. B., Modesto, M., Liddo, E. D., Specchio, L. M., Livrea, P., Trojano, M., & Avolio, C. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.04.032 · Cited by 22
Darwish, R., Alcibahy, Y., Bucheeri, S., Albishtawi, A., Tama, M., Shetty, J. K., & Butler, A. E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252313169 · Cited by 25
Jansen, M. I., Broome, S. T., & Castorina, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094788 · Cited by 21
Yokoyama, H., Kuroiwa, H., Kasahara, J., & Araki, T. (2011) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2011-1847 · Cited by 21
Minocycline Attenuates Kidney Injury in a Rat Model of Streptozotocin-Induced Diabetic Nephropathy
Yuan, H., Zhang, X., Zheng, W., Zhou, H., Zhang, B., & Zhao, D. (2016) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b15-00594 · Cited by 21
Chen, X., Ma, L., Jiang, Y., Chen, S., Zhu, C., Liu, M., Ma, X., Zhu, D., Liu, Y., Peng, F., et al. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.04.043 · Cited by 21
A Gut Feeling: The Importance of the Intestinal Microbiota in Psychiatric Disorders
Ochoa‐Repáraz, J., Ramelow, C. C., & Kasper, L. H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.510113 · Cited by 21
Chen, X., Pi, R., Liu, M., Ma, X., Jiang, Y., Liu, Y., Mao, X., & Hu, X. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.05.039 · Cited by 20
Systemic infections in multiple sclerosis and experimental autoimmune encephalomyelitis
Tauber, S. C., Nau, R., & Gerber, J. (2007) · Archives of Physiology and Biochemistry · doi:10.1080/13813450701531227 · Cited by 20
Cloarec, R., Bauer, Š., Teissier, N., Schaller, F., Luche, H., Courtens, S., Salmi, M., Pauly, V., Bois, E., Pallesi‐Pocachard, E., et al. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00055 · Cited by 19
Hou, Y., Ryu, C. H., Jun, J. A., Kim, S. M., Jeong, C. H., & Jeun, S. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.06.001 · Cited by 19
Wimmer, I., Scharler, C., Zrzavy, T., Kadowaki, T., Mödlagl, V., Rojc, K., Tröscher, A. R., Kitic, M., Ueda, S., Bradl, M., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0667-9 · Cited by 19
del Barco, D. G., Montero, E., Coro-Antich, R. M., Brown, E., Suárez-Alba, J., Lopez, L., Subirós, N., & Berlanga, J. (2011) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-2011-0595 · Cited by 18
Verma, D., Singh, D. K., Gupta, S., Gupta, P., Singh, A., Biswas, J., & Singh, S. (2018) · NeuroToxicology · doi:10.1016/j.neuro.2018.01.006 · Cited by 18
Long-term Antibiotic Treatment with Roxithromycin in Patients with Multiple Sclerosis
Woessner, R., Grauer, M. T., Frese, A., Bethke, F., Ginger, T. J., Hans, A., & Treib, J. (2006) · Infection · doi:10.1007/s15010-006-5114-8 · Cited by 18
Masocha, W., & Thomas, A. (2019) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2019.02.007 · Cited by 18
Stoop, M. P., Rosenling, T., Attali, A., Meesters, R. J. W., Stingl, C., Dekker, L. J. M., van Aken, H. H. M., Suidgeest, E., Hintzen, R. Q., Tuinstra, T., et al. (2012) · Journal of Proteome Research · doi:10.1021/pr300428e · Cited by 18
Effect of CSF1R inhibitor on glial cells population and remyelination in the cuprizone model
Tahmasebi, F., Barati, S., & Kashani, I. R. (2021) · Neuropeptides · doi:10.1016/j.npep.2021.102179 · Cited by 17
Sangobowale, M., Nikulina, E., & Bergold, P. J. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.06.010 · Cited by 17
Potts, M. B., Koh, S., Whetstone, W. D., Walker, B. A., Yoneyama, T., Claus, C. P., Manvelyan, H. M., & Noble‐Haeusslein, L. J. (2006) · Neurotherapeutics · doi:10.1007/bf03207045 · Cited by 17
Florou, D., Mavropoulos, Α., Dardiotis, E., Tsimourtou, V., Siokas, V., Aloizou, A., Liaskos, C., Tsigalou, C., Katsiari, C. G., Sakkas, L. I., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.739186 · Cited by 16
Morita, Y., Itokazu, T., Nakanishi, T., Hiraga, S.-I., & Yamashita, T. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02623-7 · Cited by 14
Minocycline promotes the generation of dendritic cells with regulatory properties
Kim, N., Park, C., Im, S., Kim, J.-W., Lee, J., Park, Y.-J., Song, S., & Lee, C. (2016) · Oncotarget · doi:10.18632/oncotarget.10810 · Cited by 16
Frykholm, B. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2008.11.045 · Cited by 16
Minocycline attenuates interferon-α-induced impairments in rat fear extinction
Bi, Q., Shi, L., Yang, P., Wang, J., & Qin, L. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0638-z · Cited by 18
Metadata
- Authors
- Popovic, N., Schubart, A., Goetz, B. D., Zhang, S., Linington, C., & Duncan, I. D.
- Affiliations
- Max Planck Society (DE)
- University of Wisconsin–Madison (US)
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2001-12-21
- Volume
- 51
- Issue
- 2
- Pages
- 215-223
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2085429548
- Cited by
- 295
- References
- 39
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 8 · 2023: 6 · 2022: 7 · 2021: 7 · 2020: 10 · 2019: 7 · 2018: 8 · 2017: 14 · 2016: 14 · 2015: 7 · 2014: 7 · 2013: 11 · 2012: 9
- FWCI
- 8.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Max Planck Digital Library (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Keywords
- minocycline, tetracycline, experimental autoimmune encephalomyelitis, multiple sclerosis, relapsing-remitting multiple sclerosis, anti-inflammatory therapy, microglial activation, MMP-2, demyelination, neuroprotection, immune deviation
- MeSH terms
- Animals, Anti-Bacterial Agents, Brain, Chronic Disease, Encephalomyelitis, Autoimmune, Experimental, Female, Immunization, Minocycline, Myelin Proteins, Recurrence, Th1 Cells, Th2 Cells, Myelin-Associated Glycoprotein, Rats, Myelin-Oligodendrocyte Glycoprotein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review